4-Antibody Ltd. is a privately held Swiss Biotech company active in the area of therapeutic antibody drug development. 4-Antibody Ltd. owns a portfolio of proprietary in vitro screening and in vivo mouse-based antibody discovery platforms for the development of fully human therapeutic antibodies.  The company has developed its first therapeutic antibody candidate, highly effective in neutralizing human cytomegalovirus infection. 4-Antibody Ltd. holds more than a dozen pending and granted patents worldwide pertaining to its technologies and antibody product candidates. The company has 40 employees working at its headquarter in Basel, Switzerland, and at a subsidiary in Jena, Germany.

Web: www.4-antibody.com